BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 9175237)

  • 21. Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock.
    Gando S; Nanzaki S; Sasaki S; Aoi K; Kemmotsu O
    Crit Care Med; 1998 Dec; 26(12):2005-9. PubMed ID: 9875912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombin generation and activation of the thrombomodulin protein C system in open heart surgery depend on the underlying cardiac disease.
    Welters I; Menges T; Ballesteros M; Knothe C; Ruwoldt R; Görlach G; Hempelmann G
    Thromb Res; 1998 Oct; 92(1):1-9. PubMed ID: 9783668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Markers of hemostatic system activation in pulmonary embolism. Changes during and after cessation of anticoagulant treatment.
    de Raucourt E; Meyer G; Landais P; Gouaref Z; Morinet P; Monge F; Sors H; Fischer AM
    Blood Coagul Fibrinolysis; 2000 Apr; 11(3):249-53. PubMed ID: 10870805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated levels of prothrombin fragment 1 + 2 indicate high risk of thrombosis.
    Ota S; Wada H; Abe Y; Yamada E; Sakaguchi A; Nishioka J; Hatada T; Ishikura K; Yamada N; Sudo A; Uchida A; Nobori T
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):279-85. PubMed ID: 18160575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical utility of prothrombin fragment 1+2, thrombin antithrombin III complexes and D-dimer measurements in the diagnosis of deep vein thrombosis following total hip replacement.
    Cofrancesco E; Cortellaro M; Corradi A; Ravasi F; Bertocchi F
    Thromb Haemost; 1998 Mar; 79(3):509-10. PubMed ID: 9531030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prothrombin activation fragment 1 + 2 and thrombin-antithrombin-III complexes in plasma of patients with essential arterial hypertension.
    Kłoczko J; Wojtukiewicz MZ; Galar M; Tarasów E; Jaromin J; Bielawiec M
    Pol J Pharmacol; 1996; 48(2):233-5. PubMed ID: 9112658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombin formation and effect of unfractionated heparin during pediatric cardiac catheterization.
    Chen D; Långström S; Petäjä J; Heikinheimo M; Pihkala J
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):1174-9. PubMed ID: 22915548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of long-term treatment with warfarin on fibrinogen, FPA, TAT, and D-dimer in patients with coronary artery disease.
    Eritsland J; Seljeflot I; Arnesen H; Smith P; Westvik AB
    Thromb Res; 1992 Apr; 66(1):55-60. PubMed ID: 1412183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coagulation activity and clinical outcome in unstable coronary artery disease.
    Oldgren J; Linder R; Grip L; Siegbahn A; Wallentin L
    Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):1059-64. PubMed ID: 11397720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma thrombin-antithrombin complex, prothrombin fragments 1 and 2, and D-dimer levels are elevated after endovascular but not open repair of infrarenal abdominal aortic aneurysm.
    Bailey MA; Griffin KJ; Sohrabi S; Whalley DJ; Johnson AB; Baxter PD; Ariëns RA; Scott DJ
    J Vasc Surg; 2013 Jun; 57(6):1512-8. PubMed ID: 23490299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic coagulation and fibrinolysis after laparoscopic and open gastric bypass.
    Nguyen NT; Owings JT; Gosselin R; Pevec WC; Lee SJ; Goldman C; Wolfe BM
    Arch Surg; 2001 Aug; 136(8):909-16. PubMed ID: 11485526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood Coagulation Changes With or Without Direct Oral Anticoagulant Therapy Following Transcatheter Aortic Valve Implantation.
    Katayama T; Yokoyama N; Watanabe Y; Takahashi S; Hioki H; Kawasugi K; Kozuma K
    Am J Cardiol; 2021 May; 147():88-93. PubMed ID: 33617810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are prothrombin fragment 1 + 2 and thrombin-antithrombin complexes useful in the management of oral anticoagulant therapy?
    Barcellona D; Biondi G; Mameli G; Marongiu F
    Int J Clin Lab Res; 1997; 27(1):76-8. PubMed ID: 9144033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurement of markers of activated coagulation in antithrombin III deficient subjects.
    Demers C; Ginsberg JS; Henderson P; Ofosu FA; Weitz JI; Blajchman MA
    Thromb Haemost; 1992 May; 67(5):542-4. PubMed ID: 1519214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in specific markers of haemostasis during reduction mammoplasty.
    Payen JF; Baruch M; Horvilleur E; Richard M; Gariod T; Polack B
    Br J Anaesth; 1998 Apr; 80(4):464-6. PubMed ID: 9640151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. D-Dimers, thrombin antithrombin III complexes and prothrombin fragments 1+2: diagnostic value in clinically suspected deep vein thrombosis.
    Boneu B; Bes G; Pelzer H; Sié P; Boccalon H
    Thromb Haemost; 1991 Jan; 65(1):28-31. PubMed ID: 2024237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombin Generation in Vitreous and Subretinal Fluid of Patients with Retinal Detachment.
    Mulder VC; Bastiaans J; van Leuven CJM; van Meurs JC; Kluft C
    Ophthalmologica; 2018; 240(1):23-28. PubMed ID: 29617690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of thromboprophylaxis duration on coagulation indicators after total hip replacement].
    Zhang H; Lin J; Li H; Guan Z; Zhou D; Kou B; Wei W
    Zhonghua Yi Xue Za Zhi; 2014 Feb; 94(7):525-8. PubMed ID: 24767296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of recombinant hirudin (r-hirudin, HBW 023) on coagulation and platelet activation in vivo. Comparison with unfractionated heparin and a low-molecular-weight heparin preparation (fragmin).
    Eichinger S; Wolzt M; Schneider B; Nieszpaur-Los M; Heinrichs H; Lechner K; Eichler HG; Kyrle PA
    Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):886-92. PubMed ID: 7600120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prothrombin activation fragment 1 + 2 and thrombin antithrombin III complexes in patients with angina pectoris: relation to the presence and severity of coronary atherosclerosis.
    Kienast J; Thompson SG; Raskino C; Pelzer H; Fechtrup C; Ostermann H; van de Loo J
    Thromb Haemost; 1993 Oct; 70(4):550-3. PubMed ID: 8115978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.